Radiotherapy and Radiosurgery Department, Humanitas Research Hospital, Milan, Rozzano, Italy.
Medical Oncology Department, Humanitas Research Hospital, Milan, Rozzano, Italy.
Med Oncol. 2019 Apr 25;36(6):48. doi: 10.1007/s12032-019-1275-z.
Postmastectomy radiotherapy (PMRT) following immediate breast reconstruction is increasingly adopted in the management of breast cancer patients. We retrospectively evaluate the complication rates of PMRT using VMAT technique to immediate tissue expander-based reconstructions and the possible impact of tissue expander volume on radiotherapy planning. We reviewed the data of patients who underwent immediate expander breast reconstruction and received PMRT with VMAT (50 Gy in 25 fractions) on the reconstructed breast and axillary levels III-IV. Neoadjuvant or adjuvant systemic therapy was administered in most of the patients. Autologous fat grafting was routinely performed at the time of second-stage reconstruction. Between 2015 and 2017, PMRT was delivered to 46 consecutive patients (median age 50 years) with expander reconstruction. Median follow-up was 27 months (range 10-41). Two patients (4.3%) had a reconstruction failure, as expander rupture and infection, following the first- and the second-stage reconstruction, respectively. In most cases expanders were completely inflated before PMRT (65.2%). Median expander volume before PMRT was 425 cm (range 150-700 cm). The amount of expander inflation did not significantly affect dosimetry, except for skin dose, with a surface receiving more than 30 Gy of 36.6 ± 0.9 cm and 47.0 ± 2.5 cm for a volume expander below or above the median, respectively. However, this variable was not predictor for complications. Disease progression was recorded in 15.2% of patients. PMRT using VMAT technique for breast cancer patients with expander reconstruction is associated with a very low complication rate. The expander volume before PMRT does not significantly compromise radiotherapy dose distribution.
乳腺癌患者术后即刻乳房重建(PMRT)后采用调强放疗(VMAT)技术,我们回顾性评估了即刻组织扩张器重建后 PMRT 的并发症发生率及扩张器体积对放疗计划的可能影响。我们对接受即刻扩张器乳房重建并接受 VMAT(50Gy/25 次)治疗的患者数据进行了回顾性分析,治疗范围包括重建乳房和腋窝 III-IV 水平。大多数患者均接受新辅助或辅助全身治疗。自体脂肪移植在二期重建时常规进行。2015 年至 2017 年,46 例接受扩张器重建的患者(中位年龄 50 岁)接受了 PMRT。中位随访时间为 27 个月(范围 10-41 个月)。两名患者(4.3%)分别在第一期和第二期重建后出现重建失败,表现为扩张器破裂和感染。在大多数情况下,在 PMRT 前,扩张器完全充气(65.2%)。PMRT 前的中位扩张器体积为 425cm(范围 150-700cm)。除皮肤剂量外,扩张器充气量对剂量分布的影响无统计学意义,分别为接受 30Gy 以上皮肤面积为 36.6±0.9cm 和 47.0±2.5cm,体积低于和高于中位数的扩张器。然而,这一变量不是并发症的预测因素。15.2%的患者记录到疾病进展。乳腺癌患者采用 VMAT 技术进行即刻乳房重建后行 PMRT,并发症发生率非常低。PMRT 前的扩张器体积不会显著影响放疗剂量分布。